top of page

Телефон: +918866862020

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Главная >

Bonrise 150 mg Tablet

Bonrise 150 mg Tablet

Manufacturer/Marketed By : Torrent Pharmaceuticals Ltd

$1.70 $1.33

Bonrise 150 mg Tablet is a prescription medication designed to help prevent skeletal complications, such as fractures, in patients battling breast cancer with bone metastases. This tablet is also beneficial...

Сворачиваемый текст идеально подходит для длинных текстов, таких как абзацы и описания. Это отличный способ предоставить людям больше информации, сохраняя при этом лаконичность макета. Вы можете связать текст с чем угодно, включая внешний веб-сайт или другую страницу. Вы можете настроить текстовое поле так, чтобы оно разворачивалось и сворачивалось при щелчке пользователя, позволяя ему прочитать больше или меньше информации.

Ibandronic acid 150 mg

Active Pharmaceutical Ingredient

Bonrise 150 mg Tablet

Артикул: Torrent Pharmaceuticals Ltd
Первоначальная цена

1,70 $

Спеццена

1,33 $

Bonrise 150 mg Tablet is a prescription medication designed to help prevent skeletal complications, such as fractures, in patients battling breast cancer with bone metastases. This tablet is also beneficial for postmenopausal women at risk of osteoporosis, a condition that weakens bones and heightens the likelihood of fractures. By working to maintain bone density, Bonrise effectively reduces the risk of spine fractures, making it a valuable option for those managing these conditions. While clinical studies support its efficacy in preventing spinal injuries, the impact of Bonrise on femoral neck fractures has yet to be confirmed. It is essential for patients to discuss their complete medical history with their healthcare provider before starting Bonrise, as certain conditions and medications may interact with its use. This ensures a safe and effective treatment plan tailored to individual needs. Always follow your healthcare professional's instructions regarding dosage and duration of therapy with Bonrise to maximize its benefits. With its dual role in treating osteoporosis and supporting cancer patients, Bonrise is a critical part of bone health management.

Active Pharmaceutical Ingredient

Ibandronic acid 150 mg

Применение

• Bonrise 150 mg tablet is utilized for the prevention of skeletal events in patients with breast cancer and bone metastases. These skeletal events may include fractures or other bone complications that require medical intervention. By using Bonrise 150 mg tablet, patients can reduce their risk of such serious outcomes. This is particularly important for those whose cancer has spread to the bones.
• Another key use of Bonrise 150 mg tablet is in the prevention of postmenopausal osteoporosis. Women who have undergone menopause often face an increased risk of developing fragile bones, which can lead to fractures. The administration of Bonrise 150 mg tablet helps to strengthen bone density in these at-risk individuals. This preventive approach is vital for maintaining bone health during and after menopause.
• Bonrise 150 mg tablet may also be indicated for patients undergoing treatments that could compromise bone health. For example, certain cancer therapies can lead to weakened bones, making it crucial to implement preventative measures. By incorporating Bonrise 150 mg tablet into their treatment regimen, patients can help safeguard their skeletal integrity. This can lead to improved quality of life and reduced complications associated with bone fragility.
• Additionally, Bonrise 150 mg tablet plays a role in the management of bone health in patients with specific risk factors for skeletal complications. Individuals with a history of fractures or those with conditions that affect bone strength can benefit from its use. By taking Bonrise 150 mg tablet, these patients may decrease their likelihood of experiencing severe bone-related issues. It serves as an important tool in proactive bone health management.

Преимущества

Bonrise 150 mg Tablet belongs to a group of medications called 'bisphosphonates' used to prevent post-menopausal osteoporosis. It is indicated in adults for the prevention of skeletal events such as pathological fractures and bone complications requiring surgery or radiotherapy in patients with bone metastases or breast cancer. Bonrise 150 mg Tablet may also be used to lower hypocalcemia (higher levels of calcium in the blood). Bonrise 150 mg Tablet suppresses the activity of osteoclasts and makes the bone stronger. It lowers the risk of getting a fracture and reduces pain in the bones. Bonrise Tablet may reverse bone loss by increasing bone mass and stopping more bone loss.

Побочные эффекты

Most adverse effects do not require medical attention and will go away when your body gets used to the medicine. Inform your doctor if any of these symptoms get severe or that bother you for a longer period.

Наиболее распространенные побочные эффекты

• Fever
• Tiredness
• Hives
• Nausea
• Indigestion
• Diarrhoea
• Heartburn
• Joint and Muscle Pain

Распространенные побочные эффекты

• Dizziness
• Inflammation in Eye
• Stomach Pain
• Irritation in Tongue, Lips, and Throat
• Asthma
• Vomiting

Как использовать

Bonrise 150 mg Tablet can be taken without food. You should take it regularly at evenly spaced intervals as per the schedule prescribed by your doctor. Taking it at the same time every day will help you to remember to take it. Do not stop taking it until you have finished, even when you feel better. It may take several days to get the full benefit of this drug. Bonrise Tablet is only part of a program of treatment that may also include changes to your diet and taking calcium and vitamin supplements.

Safety Advice

• Alcohol: It is generally not recommended to drink alcohol while taking Bonrise Tablet. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: No dose adjustment is necessary for patients with mild or moderate kidney disease, where creatinine clearance is equal to or greater than 30 ml/min. Severe kidney disease patients do not use this Bonrise Tablet.
• Breastfeeding: It is not recommended to breastfeed while taking Bonrise 150 mg. Bonrise Tablet may pass into breast milk and harm the infant. If you are breastfeeding and taking Bonrise Tablet, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Bonrise 150 mg Tablet is considered safe for use in liver disease patients. No dose adjustment is needed for such a type of patient.
• Pregnancy: Use of Bonrise 150 mg Tablet may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Bonrise Tablet during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Bonrise 150 mg Tablet does not usually affect your ability to drive.

Отказ от ответственности

Компания Sidmex Inovia стремится предоставлять точную и достоверную информацию; однако весь контент на этом веб-сайте, включая описания и состав продуктов, предназначен только для информационных целей и не должен рассматриваться как замена профессиональной медицинской консультации, диагностики или лечения.

Пользователям рекомендуется проконсультироваться с квалифицированным медицинским специалистом, прежде чем принимать какие-либо медицинские решения. Предоставленная информация не должна использоваться для самодиагностики или самолечения.

Все перечисленные продукты предназначены исключительно для B2B и оптовых запросов. Sidmex Inovia не пропагандирует прямое использование потребителями и стремится поддерживать, а не заменять отношения между медицинским работником и пациентом.

Названия продуктов, товарные знаки и бренды принадлежат их соответствующим владельцам, и их использование не подразумевает какой-либо связи или одобрения. Sidmex Inovia не несет ответственности за любые последствия, возникающие в результате использования информации, предоставленной на этом веб-сайте.

bottom of page